This brand name is authorized in Austria, Croatia, Estonia, France, Ireland, Italy, Lithuania, Poland, UK.
The drug IMVANEX contains one active pharmaceutical ingredient (API):
1
|
UNII
TU8J357395 - VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN
|
|
Smallpox vaccine is indicated for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| IMVANEX Suspension for injection | MPI, EU: SmPC | European Medicines Agency (EU) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J07BX01 | J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BX Other viral vaccines | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1621695 |
| FR | Base de données publique des médicaments | 60215623 |
| GB | Medicines & Healthcare Products Regulatory Agency | 387752 |
| IT | Agenzia del Farmaco | 042944013, 042944025 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1071082 |
| PL | Rejestru Produktów Leczniczych | 100310921 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.